Omega 3 Index Study
Not Applicable
- Conditions
- Omega 3 index, atherosclerosis, cardiovascular risk factorsdyslipoproteinemia
- Registration Number
- DRKS00028617
- Lead Sponsor
- Arbeitskreis Omega-3 e.V.
- Brief Summary
Before the intervention (T0), results show no significant differences in mean HS-omega 3 index between groups (p=0.816). After 13 weeks (T1) and 26 weeks (T2) of fish oil supplementation, significant absolut mean differences of 4.56% and 3.16% could be found (p<0,001) between groups.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 62
Inclusion Criteria
voluntary, adult
Exclusion Criteria
allgery against fish, hematophobia, coagulation disorder
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method HS omega 3 index = share of EPA and DHA on total fatty acids in the membranes of red blood cells in capillary blood samples before and after 13 weeks of intervention with a daily intake of 1500 mg omega 3 fatty acids and additional 13 weeks with 750 mg omega 3 fatty acids.
- Secondary Outcome Measures
Name Time Method triglyceride, total cholesterol, HDL and LDL concentrations measured in capillary blood cells and blood pressure.